Literature DB >> 2403354

Human urate oxidase gene: cloning and partial sequence analysis reveal a stop codon within the fifth exon.

A V Yeldandi1, X D Wang, K Alvares, S Kumar, M S Rao, J K Reddy.   

Abstract

Using the cDNA and selected genomic probes of rat urate oxidase, we have screened the human genomic library and isolated seven clones; one clone (clone 13) contained exonic regions which correspond to the exons 5, 6, and 7 of rat urate oxidase gene. The nucleotide sequence was determined for these three exons and exon/intron junctions, and compared with the sequence from the rat gene. A mutation resulting in a stop codon TGA was found in the fifth exon of the human urate oxidase gene. Sequence analysis of the polymerase chain reaction amplified DNA, corresponding to the fifth exon of urate oxidase from DNA samples from four different individuals, confirmed the same TGA stop codon in all. This single stop codon mutation and/or other mutation(s) in this gene may be responsible for the lack of urate oxidase activity in the human.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403354     DOI: 10.1016/0006-291x(90)91194-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Selective pressure on the allantoicase gene during vertebrate evolution.

Authors:  Davide Vigetti; Giorgio Binelli; Claudio Monetti; Mariangela Prati; Giovanni Bernardini; Rosalba Gornati
Journal:  J Mol Evol       Date:  2003-12       Impact factor: 2.395

2.  Transformation of Aspergillus flavus: construction of urate oxidase-deficient mutants by gene disruption.

Authors:  L Chevalet; G Tiraby; B Cabane; G Loison
Journal:  Curr Genet       Date:  1992-05       Impact factor: 3.886

3.  Rat urate oxidase produced by recombinant baculovirus expression: formation of peroxisome crystalloid core-like structures.

Authors:  K Alvares; R J Widrow; G M Abu-Jawdeh; J V Schmidt; A V Yeldandi; M S Rao; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.

Authors:  C J Danpure; P E Purdue; P Fryer; S Griffiths; J Allsop; M J Lumb; K M Guttridge; P R Jennings; J I Scheinman; S M Mauer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

5.  Isolation of the human peroxisomal acyl-CoA oxidase gene: organization, promoter analysis, and chromosomal localization.

Authors:  U Varanasi; R Chu; S Chu; R Espinosa; M M LeBeau; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  A distinct metabolic signature predicts development of fasting plasma glucose.

Authors:  Manuela Hische; Abdelhalim Larhlimi; Franziska Schwarz; Antje Fischer-Rosinský; Thomas Bobbert; Anke Assmann; Gareth S Catchpole; Andreas Fh Pfeiffer; Lothar Willmitzer; Joachim Selbig; Joachim Spranger
Journal:  J Clin Bioinforma       Date:  2012-02-02

7.  Decreased extra-renal urate excretion is a common cause of hyperuricemia.

Authors:  Kimiyoshi Ichida; Hirotaka Matsuo; Tappei Takada; Akiyoshi Nakayama; Keizo Murakami; Toru Shimizu; Yoshihide Yamanashi; Hiroshi Kasuga; Hiroshi Nakashima; Takahiro Nakamura; Yuzo Takada; Yusuke Kawamura; Hiroki Inoue; Chisa Okada; Yoshitaka Utsumi; Yuki Ikebuchi; Kousei Ito; Makiko Nakamura; Yoshihiko Shinohara; Makoto Hosoyamada; Yutaka Sakurai; Nariyoshi Shinomiya; Tatsuo Hosoya; Hiroshi Suzuki
Journal:  Nat Commun       Date:  2012-04-03       Impact factor: 14.919

8.  Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort.

Authors:  Yu Toyoda; Andrea Mančíková; Vladimír Krylov; Keito Morimoto; Kateřina Pavelcová; Jana Bohatá; Karel Pavelka; Markéta Pavlíková; Hiroshi Suzuki; Hirotaka Matsuo; Tappei Takada; Blanka Stiburkova
Journal:  Cells       Date:  2019-04-18       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.